Clinical Heterogeneity of Refractory Ascites After Pediatric Liver Transplantation Modulates Allograft Rejection Risk
Authors:
Open Access
Abstract
Refractory ascites (RA) is a severe complication that impedes long‐term survival after pediatric liver transplantation (LT), but its etiology remains complex and heterogeneous. To systematically evaluate the prognostic impact, clinical risk factors, and immunological features of RA, we retrospectively analyzed 1455 pediatric recipients who received LT in Renji Hospital between October 2016 and December 2021. RA was associated with increased mortality and graft loss after pediatric LT. Univariate analysis identified 13 clinical factors associated with RA, whereas a preliminary multivariable model showed only moderate discrimination, suggesting substantial heterogeneity among RA patients. Based on unsupervised clustering of clinical parameters, RA individuals were classified into two subgroups. Type I ascites was mainly associated with low graft‐to‐recipient weight ratio, decreased preoperative white blood cell count, and platelet count, indicating the involvement of persistent portal hypertension. In contrast, type II ascites was characterized by ABO incompatibility, elevated early postoperative soluble IL‐2 receptor, and increased risk of T‐cell‐mediated rejection, suggesting excessive alloimmune activation. These findings indicate that RA after pediatric LT comprises distinct clinical entities with different pathogenic implications. Prudent graft selection and close monitoring of immune status may help prevent RA and improve post‐transplant outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (82471804)
- National Natural Science Foundation of China (825B2017)
- National Natural Science Foundation of China (82588101)
- National Natural Science Foundation of China (82371791)
- Shanghai Municipal Health Commission (20244Y0134)
This publication has 29 references indexed in Scilit:
- Proximal Splenic Artery Embolization for Refractory Ascites and Hydrothorax Post-Liver TransplantCardioVascular and Interventional Radiology, 2023
- European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in childrenHepatology, 2021
- Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites After Liver Transplantation: Management With Proximal Splenic Artery EmbolizationTransplantation Proceedings, 2016
- Independent Risk Factors for Massive Ascites After Living Donor Liver Transplantation in AdultsTransplantation Proceedings, 2014
- Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allograftsLiver Transplantation, 2012
- Splenic artery embolization for the treatment of refractory ascites after liver transplantationLiver Transplantation, 2011
- Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipientsClinical Pharmacology & Therapeutics, 2006
- Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresisLiver Transplantation, 2006
- Ascites after liver transplantationLiver Transplantation, 2000
- Banff Schema for Grading Liver Allograft Rejection: An International Consensus DocumentHepatology, 1997